Repifermin continues to show excellent safety profile in phase II trials for various indications Dec. 13, 2001
NC-381 shows potential inhibitory effects on prostate tumor growth in preclinical studies Dec. 13, 2001
Clofarex designated an orphan drug for leukemia; encouraging clinical findings reported Dec. 12, 2001
Clinical efficacy and safety of zosuquidar as a modulator of P-glycoprotein in leukemia and lymphoma Dec. 12, 2001